Anagrelide Capsules — Class I drug recall D-0166-2021
Terminated recall by Torrent Pharma Inc, reported 2020-12-09, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0166-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Torrent Pharma Inc, Levittown, PA, United States |
| Recall initiated | 2020-11-25 |
| Classified | 2020-12-16 |
| Reported by FDA | 2020-12-09 |
| Terminated | 2022-12-28 |
| Distributed | Nationwide (US) |
| Quantity | 2,496 bottles |
| Reason classes | specification failure |
| NDC | 13668-0453, 13668-0453-01, 13668-0453-30, 13668-0462, 13668-0462-01, 13668-0462-30 |
| Lot numbers | BFD1G001 |
| Expiration dates | 2021-12 |
Product
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0166-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.